A Pat On The Back!

Beavering away at an endless Cardiovascular Clinic on a wet Thursday afternoon we sit listening with half an ear to Mrs Moana complaining that she never eats a thing and can’t understand why she’s put on …

Read More

Trial & Error?

Once again, the thorny issue of drug licensing has arisen.  The two sides to the question have been drawn up in lines of battle for years. “On your left – Mum denied new cancer cure drug” …

Read More

What’s wrong with saving lives?

Generating large profits and using sometimes dubious ethics, the pharmaceutical company are an easy target for writers. However, a recent book by James le Fanu “The Rise and Fall of Modern Medicine” (see this article in …

Read More

Cost or Benefits?

Talk of the cost of drugs is another interesting topic.  It is a question which also involves a certain amount of philosophy.  Namely, should a prescriber solely consider clinical issues when selecting a drug or should …

Read More

Pretty Poly

About ten years ago, the medical world was startled when a paper appeared proposing the combining of several medications in a so-called “polypill” to prevent cardiovascular disease.  The medications were aspirin, statin, ACE inhibitor and a …

Read More

Is Pioglitazone Safe?

At last, we have clear guidance from the European Medicines Agency on the use of pioglitazone in people with diabetes in light of the new evidence of an association with bladder cancer.  They conclude that there …

Read More